JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;134:1410-1412
© 2007 The American Association for Thoracic Surgery


Surgery for Congenital Heart Disease

Discussion

The first 300 words of the full text of this article appear below.

Dr V. Mohan Reddy. (Stanford, Calif). I would like to thank the association for the privilege of discussing this manuscript. I would also like to thank the authors for providing me with the manuscript early enough and congratulate them for an elegant presentation and study.

Dr Reemtsen and colleagues report on a 15-year single-institution experience of neonatal Ebstein’s anomaly with an overall mortality of 25% but none since 1996. This approach commits all patients to single—ventricle circulation. Probably some of these could have been a 2-ventricle or a 11/2-ventricle type of repair based on our experience and review of the literature on neonatal Ebstein’s anomaly. It might be that although this approach yields very good survival, a more balanced individualized approach might yield similar results without committing all patients to single-ventricle repairs.

In your manuscript, at least, I would say that 50% of the patients have a GOS ratio of less than 1. Perhaps in these patients a 2-ventricle or a 11/2-ventricle type of repair could be attempted as a first option.

Also, by means of right atrial reduction and RV plication, with or without, the GOS ratio immediately decreases if you do a postoperative study. But what is more important in your manuscript is the long-term follow-up and continued remodeling of the ventricle and the septum. This is, I think, the strength of your study.

The authors state that these patients were all catheterized but do not present any data on the catheterization. I have 4 or 5 questions for you, and I would appreciate if you could answer each one of them before I move on to the next.

Do you currently adopt this approach in all neonates or consider 2-ventricle repair in some? If so, what criteria do you use?

Dr Reemtsen. Our goal, . . . [Full Text of this Article]


Related Article

Fate of the right ventricle after fenestrated right ventricular exclusion for severe neonatal Ebstein anomaly
Brian L. Reemtsen, Anastasios C. Polimenakos, Brian T. Fagan, Winfield J. Wells, and Vaughn A. Starnes
J. Thorac. Cardiovasc. Surg. 2007 134: 1406-1412. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.